HLA-DQ2 antigen inhibitor (ImmunoMolecular Therapeutics)

N/A

Report date: 2025/03/20 15:14:36
NME

Base Information

Drug NameHLA-DQ2 antigen inhibitor (ImmunoMolecular Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistocompatibility antigens class II inhibitors
TargetsHistocompatibility antigens class II
Therapy Area/IndicationsCeliac Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunoMolecular Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmunoMolecular Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCeliac Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A